| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | +13.5% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥0.00B | -99.2% |
| Gross margin | 16.7% | Net margin 0.0% |
| Revenue Q/Q | -19.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.16B | 83.3% |
| R&D | ¥0.01B | 5.7% |
| SG&A | ¥0.02B | 11.1% |
| Tax & other | ¥-0.00B | -0.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
博汇股份 ・ 酷特智能 ・ 康华生物 ・ 帝科股份 ・ 胜蓝股份 ・ 山水比德 ・ 捷安高科 ・ 首都在线 ・ 中船汉光 ・ 美瑞新材 ・ 锦盛新材 ・ 新强联
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies